zintick

Macrogenics MGNX

Macrogenics Inc · Nasdaq · Pharmaceutical Preparations

$2.47+1.23%close on Oct. 28, 2026 · volume 1.4M · Yahoo Finance

Price, last 47 sessions

$3.00$4.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $4.40 · low $2.19 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Aug. 19, 2026Jeffrey Stuart Peters
Senior VP, GC, and Secretary
Sold
10b5-1 plan
31,105$4.15$129,086

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 10 →
  • 8-KOct. 23, 2026, 4:05 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

    AI summary, unreviewedMacroGenics Reports Interim Phase 1 MGC026 Data: 27% Best ORR in Heavily Pretreated SCCHN, No Discontinuations

  • 4Oct. 7, 2026, 4:22 p.m. ETView on SEC.gov
  • 8-K/ASept. 3, 2026, 4:39 p.m. ETView on SEC.gov

    Financial statements and exhibits

  • 4Aug. 20, 2026, 6:19 p.m. ETView on SEC.gov
  • 4Aug. 18, 2026, 4:19 p.m. ETView on SEC.gov
  • SCHEDULE 13G/AAug. 14, 2026, 10:22 a.m. ETView on SEC.gov
  • 10-QAug. 14, 2026, 4:19 p.m. ETView on SEC.gov
  • 8-KAug. 13, 2026, 4:07 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits